Molecular understanding of curcumin in diabetic nephropathy

Drug Discov Today. 2013 Aug;18(15-16):756-63. doi: 10.1016/j.drudis.2013.04.009. Epub 2013 May 4.

Abstract

Diabetic nephropathy is characterized by a plethora of signaling abnormalities. Recent trials have suggested that intensive glucose-lowering treatment leads to hypoglycemic events, which can be dangerous. Curcumin is the active ingredient of turmeric, which has been widely used in many countries for centuries to treat numerous diseases. The preventive and therapeutic properties of curcumin are associated with its antioxidant and anti-inflammatory properties. Here, we highlight the renoprotective role of curcumin in diabetes mellitus (DM) with an emphasis on the molecular basis of this effect. We also briefly discuss the numerous approaches that have been undertaken to improve the pharmacokinetics of curcumin.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Clinical Trials as Topic / methods
  • Curcumin / chemistry*
  • Curcumin / pharmacokinetics
  • Curcumin / therapeutic use*
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / metabolism
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / metabolism
  • Humans
  • Molecular Structure
  • Signal Transduction / physiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Curcumin